Literature DB >> 27221568

Anterolateral Advancement Pharyngoplasty: A New Technique for Treatment of Obstructive Sleep Apnea.

Tarek Abdelzaher Emara1, Mostafa Hasan Hassan2, Abdelraoof Saeed Mohamad2, Ahmad Mohamad Anany2, Ahmad Elsayed Ebrahem2.   

Abstract

OBJECTIVE: To investigate the efficacy of anterolateral advancement pharyngoplasty to enlarge pharyngeal airspace and to decrease palatal and lateral pharyngeal wall collapse in the treatment of obstructive sleep apnea (OSA). STUDY
DESIGN: Prospective study.
SETTING: University medical hospital. SUBJECTS AND
METHOD: Forty-one patients underwent an anterolateral advancement pharyngoplasty procedure according to the following criteria: body mass index <30 kg/m(2), Friedman stage II or III, type I Fujita, nocturnal polysomnography diagnostic of OSA, retropalatal and lateral pharyngeal collapse, and diagnosis with flexible nasoendoscopy during a Müller's maneuver based on a 5-point scale. Patients with retroglossal airway collapse were excluded from the study. The principle of this technique is to advance and fix the palatopharyngeus muscle with the superior pharyngeus constrictor muscle without transecting any of their fascicules anterolateral to the pterygomandibular raphe and anterosuperior to the levator veli palatine muscle.
RESULTS: Pre- and postoperative polysomnography findings (mean ± SD) showed significant statistical differences: apnea hypopnea index (AHI) decreased from 42.1 ± 16.34 to 16.3 ± 10.3 (P ≤ .001); percentage of time with oxyhemoglobin saturation <90% decreased from 18.5% ± 4.2% to 10.1% ± 1.3% (P ≤ .001); and lowest oxygen saturation level increased from 79.9% ± 14.8% to 89.3% ± 11.1% (P ≤ .05). The mean time for patients to return to a normal diet was 12.2 days. There was no postoperative bleeding, velopharyngeal insufficiency, speech alternations, or taste loss. Based on a threshold of a 50% reduction in AHI and AHI <20, surgical success was 86.8%.
CONCLUSION: Anterolateral advancement pharyngoplasty appears to be an effective technique with a high surgical success rate in the treatment of OSA patients with lateral pharyngeal wall collapse. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016.

Entities:  

Keywords:  anterolateral advancement pharyngoplasty; levator veli palatine muscle; obstructive sleep apnea palatopharyngeus muscle

Mesh:

Year:  2016        PMID: 27221568     DOI: 10.1177/0194599816648127

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  4 in total

1.  Commentary to: Long-term results of a modified expansion sphincter pharyngoplasty for sleep-disordered breathing.

Authors:  Fatih Ozdogan; Halil Erdem Ozel; Selahattin Genc; Adin Selcuk
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-04       Impact factor: 2.503

Review 2.  Palate surgery for obstructive sleep apnea: a 17-year meta-analysis.

Authors:  Kenny Peter Pang; Guillermo Plaza; Peter M Baptista J; Carlos O'Connor Reina; Yiong Huak Chan; Kathleen A Pang; Edward B Pang; Cybil Mei Zhi Wang; Brian Rotenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-25       Impact factor: 2.503

Review 3.  Manipulation of Lateral Pharyngeal Wall Muscles in Sleep Surgery: A Review of the Literature.

Authors:  Giovanni Cammaroto; Luigi Marco Stringa; Giannicola Iannella; Giuseppe Meccariello; Henry Zhang; Ahmed Yassin Bahgat; Christian Calvo-Henriquez; Carlos Chiesa-Estomba; Jerome R Lechien; Maria Rosaria Barillari; Bruno Galletti; Francesco Galletti; Francesco Freni; Cosimo Galletti; Claudio Vicini
Journal:  Int J Environ Res Public Health       Date:  2020-07-23       Impact factor: 3.390

4.  Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  David Kent; Jeffrey Stanley; R Nisha Aurora; Corinna G Levine; Daniel J Gottlieb; Matthew D Spann; Carlos A Torre; Katherine Green; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.